European organization for research and treatment of cancer QLQ-C30 and functional assessment of cancer therapy-general for measurement of quality of life in colorectal cancer patients who received adjuvant chemotherapy - A comparison

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 9, 2010, Pages 1719-1724

  Tsunoda, Akira ^a  

^a Kameda General Hospital   (Japan)

Author keywords

Colorectal cancer; EORTC QLQ C30; FACT G; Quality of life

Indexed keywords

FOLINIC ACID; TEGAFUR;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER THERAPY; CLINICAL ASSESSMENT TOOL; COLORECTAL CANCER; COMPARATIVE STUDY; DISEASE SEVERITY; EMOTION; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QLQ 30; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY GENERAL; HEALTH; HUMAN; MAJOR CLINICAL STUDY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; QUALITY OF LIFE; SOCIAL ASPECT; TOXICITY; WELLBEING;

EID: 79960793906     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376, 1993.
2. Cella DF, Tulsky DS, Gray G, et al: The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11: 570-579, 1993.
3. Kobayashi K, Takeda F, Teramukai S, et al: A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 34: 810-815, 1998.
4. Fumimoto H, Kobayashi K, Chang CH, et al: Cross-culture validation of an international questionnaire, the General Measure of the Functional Assessment of Cancer Therapy scale (FACT-G), for Japanese. Qual Life Res 10: 701-709, 2001.
5. Kemmler G, Holzner B, Kopp M, et al: Comparison of two quality-of-life instruments for cancer patients: The Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. J Clin Oncol 17: 2932-2940, 1999.
6. Kopp M, Schweigkofler H, Holzner B, et al: EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Haematol 65: 97-103, 2000. (Pubitemid 30615082)
7. Blazeby JM, Kavadas V, Vickery CW, et al: A prospective comparison of quality of life measures for patients with esophageal cancer. Qual Life Res 14: 387-393, 2005.
8. Holzner B, Bode RK, Hahn EA, et al: Equating EORTC QLQ-C30 and FACT-G scores and its use in oncological research. Eur J Cancer 42: 3169-3177, 2006. (Pubitemid 44854513)
9. Tsunoda A, Nakao K, Watanabe M, et al: Health-related quality of life in patients with colorectal cancer who receive oral uracil and tegafur plus leucovorin. Jpn J Clin Oncol 40: 412-419, 2010.
10. Fairclough DL: Patient reported outcomes as endpoints in medical research. Stat Methods Res 12: 115-138, 2004.
11. Tsunoda A, Nakao K, Hiratsuka K, et al: Prospective analysis of quality of life in the first year after colorectal cancer surgery. Acta Oncol 46: 77-82, 2007.